PositiveID Corporation (fka PSID)

[AMOTE1]

PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
PositiveID Corporation
30 minutes ago
GlobeNewswire
PositiveID's Firefly prototype device could be used to detect viruses such as Ebola and other bio-threats

DELRAY BEACH, Fla., Aug. 22, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (PSID), a developer of biological detection and diagnostics solutions, today announced that its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used to detect Ebola and other biological threats, was recently featured in Computerworld. The article titled "Mobile testing for Ebola gains renewed urgency as outbreak grows," can be found at: http://www.computerworld.com/s/article/9250361/Mobile_testing_for_Ebola_gains_renewed_urgency_as_outbreak_grows?pageNumber=1

About Firefly

PositiveID's Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time TaqMan(R) PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need in healthcare and molecular diagnostics markets for more rapid and accurate point-of-need diagnostics that will enable hospitals, physicians, military personnel, and others to save lives. Firefly can derive results from a sample in less than 20 minutes, at the point of need, compared to two to four hours for a lab device, which would enable accurate diagnostics leading to more rapid and effective treatment than what is currently available with existing systems.

About PositiveID Corporation